资讯

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain ...
Lantheus’ generic, called 177Lu-PNT2003, was licensed in December 2022 from Point Biopharma, which was acquired by Eli Lilly last month. Lantheus has worldwide rights to the drug, with the ...
You really can stop paying $4 a box for cereal because excellent generic options are typically 30% cheaper. In several blind test studies, kids who were given name-brand and generic cereals could ...
Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.
Osteoporosis is a disease that makes bones weak and more likely to break. Sometimes, a person may break a bone from a small ...
Twenty years ago, Amneal gained approval to produce the generic version of the combo, which was originally brought to the market by Roche as Bactrim in 1969. The recall comes six weeks after ...
Tesla CEO Elon Musk released the results of a drug test on X to counter the New York Times’ reporting that his drug use was “more intense" in the 2024 election.
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.
Acyclovir is a generic prescription drug that’s used to treat certain viral infections. Acyclovir comes as an oral tablet. Acyclovir oral tablet is only available as a generic drug. It doesn’t ...
A popular Mexican band has been fined more than $36,000 for performing songs glorifying drug cartels, authorities in the northern city of Chihuahua announced Wednesday. At a Los Tucanes de Tijuana ...
Doxycycline is a generic prescription medication that’s also available as the brand-name drugs Doryx, Oracea, and more. In general, generics tend to cost less than brand-name drugs. The cost of ...
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health. The new program announced ...